Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

ECO 2021 May 10 - 13

Once-Weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults With Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)

Robert F. Kushner1; W. Timothy Garvey2; Dan Hesse3; Anna Koroleva3; Soo Lim4; Ildiko Lingvay5; Ofri Mosenzon6; Signe O.R. Wallenstein3; Thomas A. Wadden7; Carel W. le Roux8;
1Northwestern University, Chicago, IL, USA; 2University of Alabama at Birmingham, Birmingham, AL, USA; 3Novo Nordisk A/S, Søborg, Denmark; 4Seoul National University Bundang Hospital, Seongnam, South Korea; 5UT Southwestern Medical Center, Dallas, TX, USA; 6Hebrew University of Jerusalem, Jerusalem, Israel; 7University of Pennsylvania, Philadelphia, PA, USA; 8University College Dublin, Dublin, Ireland;